International Journal of Green Pharmacy (Int J Green Pharm )

Publisher: MedKnow Publications, Medknow Publications

Description

Subjects: Pharmaceutics, biopharmaceutics, pharmaceutical chemistry, pharmacognosy, pharmacology, pharmaceutical analysis, pharmacy practice, clinical and hospital pharmacy.

  • Impact factor
    0.00
  • 5-year impact
    0.00
  • Cited half-life
    0.00
  • Immediacy index
    0.00
  • Eigenfactor
    0.00
  • Article influence
    0.00
  • Website
    International Journal of Green Pharmacy website
  • Other titles
    International journal of green pharmacy (online), IJGP
  • ISSN
    0973-8258
  • OCLC
    259149539
  • Material type
    Periodical, Internet resource
  • Document type
    Internet Resource, Journal / Magazine / Newspaper

Publisher details

Medknow Publications

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Non-commercial
    • Publisher's version/PDF may be used
  • Classification
    ​ green

Publications in this journal

  • International Journal of Green Pharmacy 11/2014; 8:65-71.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Generalised anxiety disorder (GAD) is characterised by a pattern of frequent, persistent worry and anxiety, which is out of proportion to the impact of the event or circumstance that is the focus of the worry. GAD is associated with muscle tension, trembling, twitching, feeling shaky and muscle aches or soreness. Many individuals with GAD also experience somatic symptoms like sweating, nausea and diarrhoea. Epidemiological studies reveal that the prevalence rate of GAD in India is 5.8%. Objective: The main objective of the present study was to evaluate the efficacy of Sarasvata choorna in the management of GAD. Materials and Methods: In this study, a total of 114 patients with GAD satisfying the Diagnostic and Statistical Manual of Mental Disorders – Text Revision (DSM IV – TR) diagnostic criteria were selected and randomly divided; of these, 102 patients completed the course of treatment. In trial group, Sarasvata choorna and in control group, placebo (wheat powder) was given with the dose of 1 g thrice a day (i.e. 3 g/day) along with madhu (honey) and ghrita (cow’s ghee) orally for 60 days. Fifteen days of follow up period was kept after treatment. Two assessments were done before and after treatment. Criterion of assessment was based on the scoring of Hamilton Anxiety Rating Scale (HAM‑A). Paired and unpaired ‘t’‑test was used for statistical analysis. Results and Conclusion: In trial group (n = 51), 51.1% improvement and in control group (n = 51), 47.67% of improvement was observed with the significance of (P < 0.001). No statistically significant difference (P > 0.05) was found in between the two groups. Sarasvata choorna did not provide better relief compared with placebo. Key words: Generalised anxiety disorder, placebo, Sarasvata choorna
    International Journal of Green Pharmacy 10/2014; 8(4):231-236.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The present study was undertaken to evolve suitable High Performance Thin Layer Chromatography (HPTLC) profile and to evaluate in vitro antioxidant activity of cow dung. Materials and Methods: Dung samples, collected from cows of Geer variety of Bos indicus on different days at predefined times, were subjected to development of HPTLC profile, estimation of total phenolic content and in vitro antioxidant activity by HPTLC‑2, 2 Diphenyl‑1‑picrylhydrazil (DPPH) bioautography, Ferric Reducing Antioxidant Power (FRAP) and DPPH free radical scavenging methods. Results: Developed HPTLC profile revealed notable variations among the samples. HPTLC‑DPPH Bioautography showed presence of number of antioxidant compounds, which was further confirmed by quantitative evaluation of in vitro antioxidant activity. The results of the study indicate presence of phenolic as well as non‑phenolic natured bio‑active compounds in cow dung. The HPTLC profile as well as antioxidant potential of cow dung is reported for the first time with notable intra‑day and inter‑day variations. The evolved chromatographic profile will be very useful for evaluating the quality of cow dung. It has potential as a natural antioxidant.
    International Journal of Green Pharmacy 09/2014; 8(3):158-162.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Attention–Deficit/Hyperactivity Disorder (ADHD) is the most commonly diagnosed childhood psychiatric disorder. Children with ADHD have been found to have cognitive deficits, lower IQ, impaired social relationships with in the family and with peers as well as poor study skills and lower academic achievement. ADHD prevalence is estimated to be 5% for the Indian paediatric population. The persistence of these problems highlights the need for effective treatment. Objective: The main objective of the present study was to evaluate the comparative effect of Naladadi Ghrita with Kushmanda Ghrita in reducing the signs and symptoms of ADHD. Materials and Methods: A total of 20 subjects with ADHD satisfying the DSM‑IV TR diagnostic criteria were selected and divided in to two groups by following randomisation method. Trial group received Naladadi Ghrita 5 ml twice a day and control group received Kushmanda Ghrita 5 ml twice a day for 1 month. Two assessments were done before and after the treatment. Criterion of assessment was based on the scoring of ADHD Rating Scale. Paired and unpaired ‘t’‑test was used for statistical analysis. Results and Conclusion: Naladadi Ghrita and Kushmanda Ghrita both were effective on ADHD Rating Scale and they provided 35%, 38.68% of relief, respectively (P < 0.001). The difference in between the both groups was statistically insignificant (P > 0.05). Key words: ADHD rating scale, attention–deficit/hyperactivity disorder, Kushmanda ghrita, Naladadi ghrita
    International Journal of Green Pharmacy 11/2013; 7(4):322-327.
  • International Journal of Green Pharmacy 11/2013; 7(4):265-273.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Habbe Shifa (HS) is an important pharmacopoeial Unani formulation, which is used in the treatment of Humma (fever), Iya (fatigue), Tashannuje rewi (pulmonary spasm) and Zeequn Nafas (asthma) and opium deaddiction. Aim: Background: The physico‑chemical standards of HS were established in the present study. Materials and Methods: HS was prepared with ingredients of particle size 150 µm (100 mesh sieve), 5% w/w Gum Acacia mucilage was used as binder, dried at a temperature 90°C for 120 min and finally evaluated for different physico‑chemical parameters to develop standards for HS. Results and Conclusion: Physico‑chemical standards of HS were observed as characteristic brown colour, spherical shape, hard in texture, odourless and bitter in taste; average weight 242.95 ± 1.53 mg; diameter 7.33 ± 0.16 mm; hardness 3.5 ± 0.00 kg/cm; friability 0.02 ± 0.003%; pH value in 1% and 10% aqueous solution 6.22 ± 0.06 and 5.39 ± 0.008 respectively; percentage loss of weight on drying at 105°C 6.63 ± 0.12%; total ash, acid insoluble ash and water soluble ash 5.33 ± 0.16, 0.95 ± 0.05 and 1 ± 0.00% respectively and total alkaloid 0.65 ± 0.01% and Rf values in the thin layer chromatography in ethanolic extract in hexane: Acetone (7.6:2.4) solvent system were 0.25, 0.78 and in hexane: Diethyl ether (4:6) solvent system were 0.58, 0.89. The results obtained for the various physico‑chemical tests of lab sample of HS may be taken as standard parameter for future reference and help in setting up regulatory limit to assure the quality of Unani medicine. Key words: Habbe Shifa, physico‑chemical, standardization
    International Journal of Green Pharmacy 04/2013; Volume 7(Issue 2):162-66.